Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

Overview of attention for article published in The Pharmacogenomics Journal, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 964)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet
twitter: 6 X users

patent: 3 patents

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 39,875 followers.

Response to interferonbeta treatment in multiple sclerosis patients a genomewide null https://t.co/x9ZTISF9Hl #DTHSTR

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study https://t.co/zimqUJCfgB

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study https://t.co/0AkkfY0jpz

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study. - PubMed -https://t.co/VKIwoFOsXz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.